October 1, 2021 By Erin S. Tomiyama, OD, MS, and Kathryn Richdale, OD, PhD The ultimate choice of when to stop must...
sponsored content October 1, 2021 By Dwight Akerman, OD, MBA, FAAO, FBCLA Vyluma is dedicated to using its deep expertise to develop...
September 15, 2021 By Michael Dittman, OD; Dittman Eyecare, Butler, PA My associate doctors and I do our best to educate parents...
September 15, 2021 By Andrei V. Tkatchenko, MD, PhD, and Tatiana V. Tkatchenko, MD The development of effective and safe drugs for...
August 16, 2021 By Katherine Schuetz, OD; RevolutionEYES and Little Eyes Pediatric Eye Care, Carmel, IN As our profession learns to embrace...
A summary of the LAMP Study results
When should one start atropine treatment for myopes?
April 1, 2020 By Dwight Akerman, OD, MBA, FAAO, FBCLA Topical low-dose atropine is an emerging therapy for myopia management, but its...
August 2, 2021 By Dwight Akerman, OD, MBA, FAAO, FBCLA Several products and interventions — which have been proposed for reducing the...
August 2, 2021 By Vishakha Thakrar, OD; Vaughan Family Vision Care, Ontario, Canada Since we started utilizing novel spectacle lenses, we have...
July 15, 2021 By Melanie Frogozo, OD, FAAO, Alamo Eye Care , San Antonio, Texas To give children the greatest chance of...
October 1, 2020 By Huy Tran, MD, and Thao Ha, MD Myopia is the most common refractive error worldwide and is estimated...
June 24, 2020 By Dwight Akerman, OD, MBA, FAAO, FBCLA Chief Medical Editor, Review of Myopia Management The use of atropine to...
June 12, 2020 The clinical-stage ophthalmic biopharmaceutical company Eyenovia is developing a microdose treatment that is designed to improve the delivery of...
June 1, 2020 By Dwight Akerman, OD, MBA, FAAO Myopia is characterized by excessive axial elongation because of an increase in the...
December 1, 2020 By Dwight Akerman, OD, MBA, FAAO, FBCLA In this randomized, placebo-controlled, double-masked study, researchers tested the safety and effectiveness...
May 1, 2020 By Laura Kirkeby, CO The use of atropine has been known to slow the progression of myopia for many...
There are two strategies to consider for stopping atropine treatment.
March 1, 2020 By Dwight Akerman, OD, MBA, FAAO Chief Medical Editor, Review of Myopia Management To assess the effects of interventions...
Individual interventions may not result in the expected efficacy.
This summary of an International Myopia Institute (IMI) white paper was created by and is used with permission from the Centre for...
Presently, only atropine, pirenzepine, and 7-methylxanthine are shown to reduce myopia progression in human trials.
The researchers concluded that topical low-dose atropine appears to be safe and effective in a cohort of European schoolchildren.
Axial elongation rate is faster in younger children undergoing ortho-k treatment.